Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II): An Open-Label, Randomised Controlled Trial

Kim Broekhuijsen; Gert-Jan van Baaren; Maria G. van Pampus; Wessel Ganzevoort; J. Marko Sikkema; Mallory D. Woiski; Martijn A. Oudijk; Kitty W. M. Bloemenkamp; Hubertina C. J. Scheepers; Henk A. Bremer; Robbert J. P. Rijnders; Aren J. van Loon; Denise A. M. Perquin; Jan M. J. Sporken; Dimitri N. M. Papatsonis; Marloes E. van Huizen; Corla B. Vredevoogd; Jozien T. J. Brons; Mesrure Kaplan; Anton H. van Kaam; Henk Groen; Martina M. Porath; Paul P. van den Berg; Ben W. J. Mol; Maureen T. M. Franssen; Josje Langenveld; HYPITAT-II Study Grp

doi:10.1097/01.ogx.0000472156.82018.61

Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II): An Open-Label, Randomised Controlled Trial

Kim Broekhuijsen^*, Gert-Jan van Baaren, Maria G. van Pampus, Wessel Ganzevoort, J. Marko Sikkema, Mallory D. Woiski, Martijn A. Oudijk, Kitty W. M. Bloemenkamp, Hubertina C. J. Scheepers, Henk A. Bremer, Robbert J. P. Rijnders, Aren J. van Loon, Denise A. M. Perquin, Jan M. J. Sporken, Dimitri N. M. Papatsonis, Marloes E. van Huizen, Corla B. Vredevoogd, Jozien T. J. Brons, Mesrure Kaplan, Anton H. van KaamHenk Groen, Martina M. Porath, Paul P. van den Berg, Ben W. J. Mol, Maureen T. M. Franssen, Josje Langenveld, HYPITAT-II Study Grp

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Abstract

Patients with hypertensive disorders of pregnancy usually have the 2 treatment options, either immediate delivery or continuing the pregnancy. Although immediately delivery of the placenta is seen as the more definitive of the 2 treatments, it does carry the potentially higher risks of an earlier birth (preterm if

Original language	English
Pages (from-to)	605-607
Number of pages	3
Journal	Obstetrical & Gynecological Survey
Volume	70
Issue number	10
DOIs	https://doi.org/10.1097/01.ogx.0000472156.82018.61
Publication status	Published - Oct-2015

Access to Document

10.1097/01.ogx.0000472156.82018.61

Handle.net

Persistent link

Cite this

Broekhuijsen, K., van Baaren, G.-J., van Pampus, M. G., Ganzevoort, W., Sikkema, J. M., Woiski, M. D., Oudijk, M. A., Bloemenkamp, K. W. M., Scheepers, H. C. J., Bremer, H. A., Rijnders, R. J. P., van Loon, A. J., Perquin, D. A. M., Sporken, J. M. J., Papatsonis, D. N. M., van Huizen, M. E., Vredevoogd, C. B., Brons, J. T. J., Kaplan, M., ... HYPITAT-II Study Grp (2015). Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II): An Open-Label, Randomised Controlled Trial. Obstetrical & Gynecological Survey, 70(10), 605-607. https://doi.org/10.1097/01.ogx.0000472156.82018.61

@article{13f58b80602c42ed8f4107eec0f3eee5,

title = "Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II): An Open-Label, Randomised Controlled Trial",

abstract = "Patients with hypertensive disorders of pregnancy usually have the 2 treatment options, either immediate delivery or continuing the pregnancy. Although immediately delivery of the placenta is seen as the more definitive of the 2 treatments, it does carry the potentially higher risks of an earlier birth (preterm if",

author = "Kim Broekhuijsen and {van Baaren}, Gert-Jan and {van Pampus}, {Maria G.} and Wessel Ganzevoort and Sikkema, {J. Marko} and Woiski, {Mallory D.} and Oudijk, {Martijn A.} and Bloemenkamp, {Kitty W. M.} and Scheepers, {Hubertina C. J.} and Bremer, {Henk A.} and Rijnders, {Robbert J. P.} and {van Loon}, {Aren J.} and Perquin, {Denise A. M.} and Sporken, {Jan M. J.} and Papatsonis, {Dimitri N. M.} and {van Huizen}, {Marloes E.} and Vredevoogd, {Corla B.} and Brons, {Jozien T. J.} and Mesrure Kaplan and {van Kaam}, {Anton H.} and Henk Groen and Porath, {Martina M.} and {van den Berg}, {Paul P.} and Mol, {Ben W. J.} and Franssen, {Maureen T. M.} and Josje Langenveld and {HYPITAT-II Study Grp}",

year = "2015",

month = oct,

doi = "10.1097/01.ogx.0000472156.82018.61",

language = "English",

volume = "70",

pages = "605--607",

journal = "Obstetrical & Gynecological Survey",

issn = "0029-7828",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "10",

}

Broekhuijsen, K, van Baaren, G-J, van Pampus, MG, Ganzevoort, W, Sikkema, JM, Woiski, MD, Oudijk, MA, Bloemenkamp, KWM, Scheepers, HCJ, Bremer, HA, Rijnders, RJP, van Loon, AJ, Perquin, DAM, Sporken, JMJ, Papatsonis, DNM, van Huizen, ME, Vredevoogd, CB, Brons, JTJ, Kaplan, M, van Kaam, AH, Groen, H, Porath, MM, van den Berg, PP, Mol, BWJ, Franssen, MTM, Langenveld, J & HYPITAT-II Study Grp 2015, 'Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II): An Open-Label, Randomised Controlled Trial', Obstetrical & Gynecological Survey, vol. 70, no. 10, pp. 605-607. https://doi.org/10.1097/01.ogx.0000472156.82018.61

Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II): An Open-Label, Randomised Controlled Trial. / Broekhuijsen, Kim; van Baaren, Gert-Jan; van Pampus, Maria G. et al.
In: Obstetrical & Gynecological Survey, Vol. 70, No. 10, 10.2015, p. 605-607.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II)

T2 - An Open-Label, Randomised Controlled Trial

AU - Broekhuijsen, Kim

AU - van Baaren, Gert-Jan

AU - van Pampus, Maria G.

AU - Ganzevoort, Wessel

AU - Sikkema, J. Marko

AU - Woiski, Mallory D.

AU - Oudijk, Martijn A.

AU - Bloemenkamp, Kitty W. M.

AU - Scheepers, Hubertina C. J.

AU - Bremer, Henk A.

AU - Rijnders, Robbert J. P.

AU - van Loon, Aren J.

AU - Perquin, Denise A. M.

AU - Sporken, Jan M. J.

AU - Papatsonis, Dimitri N. M.

AU - van Huizen, Marloes E.

AU - Vredevoogd, Corla B.

AU - Brons, Jozien T. J.

AU - Kaplan, Mesrure

AU - van Kaam, Anton H.

AU - Groen, Henk

AU - Porath, Martina M.

AU - van den Berg, Paul P.

AU - Mol, Ben W. J.

AU - Franssen, Maureen T. M.

AU - Langenveld, Josje

AU - HYPITAT-II Study Grp

PY - 2015/10

Y1 - 2015/10

N2 - Patients with hypertensive disorders of pregnancy usually have the 2 treatment options, either immediate delivery or continuing the pregnancy. Although immediately delivery of the placenta is seen as the more definitive of the 2 treatments, it does carry the potentially higher risks of an earlier birth (preterm if

AB - Patients with hypertensive disorders of pregnancy usually have the 2 treatment options, either immediate delivery or continuing the pregnancy. Although immediately delivery of the placenta is seen as the more definitive of the 2 treatments, it does carry the potentially higher risks of an earlier birth (preterm if

U2 - 10.1097/01.ogx.0000472156.82018.61

DO - 10.1097/01.ogx.0000472156.82018.61

M3 - Editorial

SN - 0029-7828

VL - 70

SP - 605

EP - 607

JO - Obstetrical & Gynecological Survey

JF - Obstetrical & Gynecological Survey

IS - 10

ER -

Broekhuijsen K, van Baaren GJ, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD et al. Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II): An Open-Label, Randomised Controlled Trial. Obstetrical & Gynecological Survey. 2015 Oct;70(10):605-607. doi: 10.1097/01.ogx.0000472156.82018.61

Immediate Delivery Versus Expectant Monitoring for Hypertensive Disorders of Pregnancy Between 34 and 37 Weeks of Gestation (HYPITAT-II): An Open-Label, Randomised Controlled Trial

Abstract

Access to Document

Handle.net

Fingerprint

Cite this